Patents by Inventor Sonia DAS

Sonia DAS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-CD39 antibody compositions and methods
    Patent number: 11655303
    Abstract: The invention provides anti-CD39 antibody compositions and their use in treating cancer.
    Type: Grant
    Filed: September 15, 2020
    Date of Patent: May 23, 2023
    Assignee: Surface Oncology, Inc.
    Inventors: Scott Chappel, Andrew Lake, Michael Warren, Austin Dulak, Erik Devereaux, Pamela M. Holland, Tauqeer Zaidi, Matthew Rausch, Bianka Prinz, Nels P. Nielson, Sonia Das, Alison M. O'Neill
  • Anti-CD39 Antibody Compositions and Methods
    Publication number: 20220372160
    Abstract: The invention provides anti-CD39 antibody compositions and their use in treating cancer. In some embodiments, an isolated anti-CD39 antibody is provided. Such an isolated anti-CD39 antibody binds to human CD39, wherein the antibody is optionally fully human or humanized. In some embodiments, the disclosure provides a method of enhancing, increasing and/or sustaining an anti-tumor immune response in a subject comprising administering the antibody or composition described herein to a subject having a tumor.
    Type: Application
    Filed: September 15, 2020
    Publication date: November 24, 2022
    Applicant: Surface Oncology, Inc.
    Inventors: Scott CHAPPEL, Andrew LAKE, Michael WARREN, Austin DULAK, Erik DEVEREAUX, Pamela M. HOLLAND, Tauqeer ZAIDI, Matthew RAUSCH, Bianka Prinz, Nels P. NIELSON, Sonia DAS, Alison M. O'Neill
  • Antibodies That Bind CD39 and Uses Thereof
    Publication number: 20210363268
    Abstract: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.
    Type: Application
    Filed: March 13, 2019
    Publication date: November 25, 2021
    Applicant: Surface Oncology, Inc.
    Inventors: Scott CHAPPEL, Andrew LAKE, Michael WARREN, Austin DULAK, Erik DEVEREAUX, Pamela M. HOLLAND, Tauqeer ZAIDI, Matthew RAUSCH, Bianka Prinz, Nels P. NIELSON, Sonia DAS
  • Anti-CD39 Antibody Compositions and Methods
    Publication number: 20210095041
    Abstract: The invention provides anti-CD39 antibody compositions and their use in treating cancer.
    Type: Application
    Filed: September 15, 2020
    Publication date: April 1, 2021
    Applicant: Surface Oncology, Inc.
    Inventors: Scott CHAPPEL, Andrew LAKE, Michael WARREN, Austin DULAK, Erik DEVEREAUX, Pamela M. HOLLAND, Tauqeer ZAIDI, Matthew RAUSCH, Bianka Prinz, Nels P. NIELSON, Sonia DAS, Alison M. O'Neill
  • Antibodies That Bind CD39 and Uses Thereof
    Publication number: 20200399394
    Abstract: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.
    Type: Application
    Filed: September 9, 2020
    Publication date: December 24, 2020
    Applicant: Surface Oncology, Inc.
    Inventors: Scott CHAPPEL, Andrew LAKE, Michael WARREN, Austin DULAK, Erik DEVEREAUX, Pamela M. HOLLAND, Tauqeer ZAIDI, Matthew RAUSCH, Bianka Prinz, Nels P. NIELSON, Sonia DAS
  • Antibodies that bind CD39 and uses thereof
    Patent number: 10793637
    Abstract: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.
    Type: Grant
    Filed: May 13, 2020
    Date of Patent: October 6, 2020
    Assignee: Surface Oncology, Inc.
    Inventors: Scott Chappel, Andrew Lake, Michael Warren, Austin Dulak, Erik Devereaux, Pamela M. Holland, Tauqeer Zaidi, Matthew Rausch, Bianka Prinz, Nels P. Nielson, Sonia Das
  • Antibodies That Bind CD39 and Uses Thereof
    Publication number: 20200277394
    Abstract: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.
    Type: Application
    Filed: May 13, 2020
    Publication date: September 3, 2020
    Applicant: Surface Oncology, Inc.
    Inventors: Scott CHAPPEL, Andrew LAKE, Michael WARREN, Austin DULAK, Erik DEVEREAUX, Pamela M. HOLLAND, Tauqeer ZAIDI, Matthew RAUSCH, Bianka Prinz, Nels P. NIELSON, Sonia DAS
  • Antibodies that bind CD39 and uses thereof
    Patent number: 10738128
    Abstract: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.
    Type: Grant
    Filed: March 13, 2019
    Date of Patent: August 11, 2020
    Assignee: Surface Oncology, Inc.
    Inventors: Scott Chappel, Andrew Lake, Michael Warren, Austin Dulak, Erik Devereaux, Pamela M. Holland, Tauqeer Zaidi, Matthew Rausch, Bianka Prinz, Nels P. Nielson, Sonia Das
  • Antibodies That Bind CD39 and Uses Thereof
    Publication number: 20190284295
    Abstract: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.
    Type: Application
    Filed: March 13, 2019
    Publication date: September 19, 2019
    Inventors: Scott CHAPPEL, Andrew LAKE, Michael WARREN, Austin DULAK, Erik DEVEREAUX, Pamela M. HOLLAND, Tauqeer ZAIDI, Matthew RAUSCH, Bianka Prinz, Nels P. NIELSON, Sonia DAS